Foreign investment in pharma; walking a thin line - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Foreign investment in pharma; walking a thin line

Oct 9, 2013

Here is today's recommended reading list from Equitymaster...

Are strict regulations stifling investment in retail?
Walmart put its retail venture in India on the backburner and ended its joint venture with Bharti Enterprises. The world's largest retailer cited the mandatory requirement of 30% of the product sourcing from local businesses as an impediment as it does not provide a level playing field. The opening of FDI in multi-brand retail last year has failed to attract large foreign chains due to the changed government regulations. Read on to know more... (The New York Times Company)

Foreign investment in pharma; walking a thin line
The 100% FDI in the pharma sector has seen a clutch of big-ticket acquisition of domestic companies by foreign multinationals since 2008. However, the health ministry is concerned that foreign companies have not invested in creating new capacities, research & development and in turn new employment in the country. Moreover, with the market share of multinationals going up in the Indian pharmaceutical markets, domestic capability will dwindle and keeping prices of essential drugs under control will become difficult. The DIPP has suggested new rules for FDI to check this. But will this dent the inflow of foreign capital in the long run. Read on to know more. (The Economist Intelligence Unit Limited)

The conundrum of equity returns
What factors influence the return on equity? The author of the article believes that return on equity does not depend on the GDP growth of the economy. The only reason, equity as an asset class tends to offer high returns is the significantly high risk element carried by it. Read on to know more. (GMO)

Will US stimulus measures be pulled back soon?
Speculations about the pullback of stimulus measures have kept global markets on the edge. However the recent development arising out of the US shutdown has lent credence to the winding up program being deferred. The US shutdown has economic costs in terms of lost growth. Therefore longer the shutdown, higher is magnitude of the losses incurred. Therefore to soften the blow, the Fed may continue its stimulus program. Apart from that factors such as absence of data during the shutdown and leadership change may lead to the stimulus program being extended until 2014, feels the author. Read on to know more... (Cable News Network)

Is India's macro economic situation improving?
Aided by lower imports of gold and oil coupled with jump in exports, India's trade deficit in September reduced substantially. This has increased hopes for an improvement in the country's otherwise gloomy economic outlook. Read on to find out more about this strong rebound. (Dow Jones & Company)

Madhu Gupta

Madhu Gupta (Research Analyst), ValuePro has a post graduate degree in both physics and finance. Having worked with India's leading economic research agency, she has a natural flair for numbers and analytics. She brings with her a near-decade long rich experience in the field of finance. A firm believer of the principles of value investing, she looks for robust businesses with durable competitive advantages.

This article is for information purposes only. The link in this article will let the User leave and proceed to the linked article. The User's use of each such site is subject to Terms of Use on and other terms of use, if any, contained within each such site. Any data and charts if used, in the article have not been authenticated by Equitymaster and Equitymaster do not claim it to be accurate nor accept any responsibility for the same. The views, if any in the linked article are not of Equitymaster. Equitymaster will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any investment decisions based on this article. Please read the detailed Terms of Use of the web site.

Equitymaster requests your view! Post a comment on "Foreign investment in pharma; walking a thin line". Click here!


More Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 6, 2021 02:52 PM